 Antal Zemplenyi
Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Costs | 2 | 2025 | 116 | 1.650 |
Why?
| | Cost-Benefit Analysis | 6 | 2025 | 636 | 1.270 |
Why?
| | Medicare | 4 | 2025 | 887 | 1.020 |
Why?
| | Comparative Effectiveness Research | 2 | 2025 | 170 | 0.970 |
Why?
| | Genetic Therapy | 2 | 2025 | 313 | 0.920 |
Why?
| | Reimbursement Mechanisms | 1 | 2025 | 80 | 0.840 |
Why?
| | Negotiating | 4 | 2025 | 34 | 0.840 |
Why?
| | Medicaid | 2 | 2025 | 462 | 0.800 |
Why?
| | Hemophilia B | 1 | 2023 | 66 | 0.770 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2025 | 199 | 0.760 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2026 | 988 | 0.730 |
Why?
| | Technology Assessment, Biomedical | 4 | 2024 | 44 | 0.730 |
Why?
| | Hemophilia A | 1 | 2023 | 147 | 0.690 |
Why?
| | Anemia, Sickle Cell | 1 | 2025 | 312 | 0.650 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2026 | 1182 | 0.600 |
Why?
| | Qualitative Research | 1 | 2024 | 1671 | 0.480 |
Why?
| | Lung Neoplasms | 2 | 2026 | 2642 | 0.440 |
Why?
| | United States | 7 | 2025 | 15988 | 0.300 |
Why?
| | Artificial Intelligence | 2 | 2024 | 367 | 0.280 |
Why?
| | Markov Chains | 1 | 2025 | 129 | 0.210 |
Why?
| | Models, Economic | 1 | 2025 | 62 | 0.210 |
Why?
| | Germany | 1 | 2024 | 138 | 0.200 |
Why?
| | Psychotherapy | 1 | 2024 | 191 | 0.190 |
Why?
| | Delphi Technique | 1 | 2024 | 331 | 0.180 |
Why?
| | Patient Participation | 2 | 2024 | 433 | 0.180 |
Why?
| | Biomedical Technology | 1 | 2020 | 49 | 0.160 |
Why?
| | Humans | 14 | 2026 | 144957 | 0.150 |
Why?
| | Patient-Centered Care | 1 | 2023 | 544 | 0.140 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2024 | 893 | 0.120 |
Why?
| | Colorado | 1 | 2025 | 4564 | 0.110 |
Why?
| | Aged | 4 | 2026 | 25947 | 0.090 |
Why?
| | Aged, 80 and over | 1 | 2025 | 8279 | 0.090 |
Why?
| | Male | 3 | 2026 | 72406 | 0.070 |
Why?
| | Serotonin and Noradrenaline Reuptake Inhibitors | 1 | 2024 | 6 | 0.050 |
Why?
| | Economics, Medical | 1 | 2024 | 6 | 0.050 |
Why?
| | Quality-Adjusted Life Years | 1 | 2024 | 121 | 0.050 |
Why?
| | Checklist | 1 | 2024 | 108 | 0.050 |
Why?
| | Stakeholder Participation | 1 | 2023 | 84 | 0.050 |
Why?
| | Consensus | 1 | 2024 | 489 | 0.040 |
Why?
| | Europe | 1 | 2022 | 412 | 0.040 |
Why?
| | Female | 2 | 2026 | 78376 | 0.040 |
Why?
| | Canada | 1 | 2020 | 428 | 0.040 |
Why?
| | Research Design | 1 | 2024 | 1137 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 6053 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11695 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4275 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2026 | 17101 | 0.020 |
Why?
| | Middle Aged | 1 | 2026 | 35928 | 0.010 |
Why?
| | Child | 1 | 2022 | 22657 | 0.010 |
Why?
|
|
Zemplenyi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|